| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $741K | -23.2% | -40.7% |
| R&D Expense | $23.9M | +71.3% | +42.7% |
| SG&A Expense | $5.2M | -7.0% | +11.7% |
| Operating Income | -$28.4M | -52.7% | -40.9% |
| Pre-tax Income | -$31.5M | -100.8% | -64.2% |
| Income Tax | $56K | -69.7% | -38.5% |
| Net Income | -$31.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $41.9M | +124.8% | +18.7% |
| Short-term Investments | $57.1M | -45.2% | +44.4% |
| Current Assets | $103.4M | -19.2% | +29.6% |
| Total Assets | $109.8M | -18.5% | +24.1% |
| Current Liabilities | $22.0M | +8.5% | +4.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$60.8M | — | — |
| Investing Cash Flow | -$35.8M | — | — |
| Financing Cash Flow | $101.5M | — | — |
| -98.8% |
| -63.8% |
| EPS (Basic) | -$3.04 | -98.7% | +1.0% |
| EPS (Diluted) | -$3.04 | -98.7% | +1.0% |
| $37.9M |
| +15.5% |
| -1.0% |
| Stockholders' Equity | $71.8M | -29.5% | +43.4% |